160 related articles for article (PubMed ID: 12370130)
1. Proposal for a new UVA protection factor: use of an in vitro model of immediate pigment darkening.
Routaboul C; Denis A; Bohbot M
Eur J Dermatol; 2002; 12(5):439-44. PubMed ID: 12370130
[TBL] [Abstract][Full Text] [Related]
2. Immediate pigment-darkening reaction.
Beitner H
Photodermatol; 1988 Apr; 5(2):96-100. PubMed ID: 3041388
[TBL] [Abstract][Full Text] [Related]
3. Immediate pigment darkening and persistent pigment darkening as means of measuring the ultraviolet A protection factor in vivo: a comparative study.
Hwang YJ; Park HJ; Hahn HJ; Kim JY; Ko JH; Lee YW; Choe YB; Ahn KJ
Br J Dermatol; 2011 Jun; 164(6):1356-61. PubMed ID: 21250967
[TBL] [Abstract][Full Text] [Related]
4. The COLIPA in vitro UVA method: a standard and reproducible measure of sunscreen UVA protection.
Matts PJ; Alard V; Brown MW; Ferrero L; Gers-Barlag H; Issachar N; Moyal D; Wolber R
Int J Cosmet Sci; 2010 Feb; 32(1):35-46. PubMed ID: 20412201
[TBL] [Abstract][Full Text] [Related]
5. Topical chloroquine applied before irradiation protects against ultraviolet B (UVB)- and UVA-induced erythema but not against immediate pigment darkening.
Sjölin-Forsberg G; Lindström B; Berne B
Photodermatol Photoimmunol Photomed; 1992-1993 Oct; 9(5):220-4. PubMed ID: 1342192
[TBL] [Abstract][Full Text] [Related]
6. Prevention of ultraviolet-induced skin pigmentation.
Moyal D
Photodermatol Photoimmunol Photomed; 2004 Oct; 20(5):243-7. PubMed ID: 15379874
[TBL] [Abstract][Full Text] [Related]
7. Decreased human epidermal antigen-presenting cell activity after ultraviolet A exposure: dose-response effects and protection by sunscreens.
Stoebner PE; Poosti R; Djoukelfit K; Martinez J; Meunier L
Br J Dermatol; 2007 Jun; 156(6):1315-20. PubMed ID: 17535231
[TBL] [Abstract][Full Text] [Related]
8. Development of a human in vivo method to study the effect of ultraviolet radiation and sunscreens in melanocytic nevi.
Carrera C; Puig S; Llambrich A; Palou J; Lecha M; Massi D; Malvehy J
Dermatology; 2008; 217(2):124-36. PubMed ID: 18503257
[TBL] [Abstract][Full Text] [Related]
9. An in vitro strategy to evaluate the phototoxicity of solar UV at the molecular and cellular level: application to photoprotection assessment.
Marrot L; Belaidi JP; Chaubo C; Meunier JR; Perez P; Agapakis-Causse C
Eur J Dermatol; 1998 Sep; 8(6):403-12. PubMed ID: 9729050
[TBL] [Abstract][Full Text] [Related]
10. Comparison of UVA protection afforded by high sun protection factor sunscreens.
Bissonnette R; Allas S; Moyal D; Provost N
J Am Acad Dermatol; 2000 Dec; 43(6):1036-8. PubMed ID: 11100019
[TBL] [Abstract][Full Text] [Related]
11. Photoprotection of bacterial-derived melanin against ultraviolet A-induced cell death and its potential application as an active sunscreen.
Geng J; Tang W; Wan X; Zhou Q; Wang XJ; Shen P; Lei TC; Chen XD
J Eur Acad Dermatol Venereol; 2008 Jul; 22(7):852-8. PubMed ID: 18312329
[TBL] [Abstract][Full Text] [Related]
12. A qualitative and quantitative transmission electronmicroscopic study of the immediate pigment darkening reaction.
Beitner H; Wennersten G
Photodermatol; 1985 Oct; 2(5):273-8. PubMed ID: 4070025
[TBL] [Abstract][Full Text] [Related]
13. The sun protection factor (SPF) inadequately defines broad spectrum photoprotection: demonstration using skin reconstructed in vitro exposed to UVA, UVBor UV-solar simulated radiation.
Bernerd F; Vioux C; Lejeune F; Asselineau D
Eur J Dermatol; 2003; 13(3):242-9. PubMed ID: 12804982
[TBL] [Abstract][Full Text] [Related]
14. Broad-spectrum sunscreens provide better protection from solar ultraviolet-simulated radiation and natural sunlight-induced immunosuppression in human beings.
Moyal DD; Fourtanier AM
J Am Acad Dermatol; 2008 May; 58(5 Suppl 2):S149-54. PubMed ID: 18410801
[TBL] [Abstract][Full Text] [Related]
15. Immediate pigment darkening: description, kinetic and biological function.
Routaboul C; Denis A; Vinche A
Eur J Dermatol; 1999 Mar; 9(2):95-9. PubMed ID: 10066954
[TBL] [Abstract][Full Text] [Related]
16. Sunscreens containing the broad-spectrum UVA absorber, Mexoryl SX, prevent the cutaneous detrimental effects of UV exposure: a review of clinical study results.
Fourtanier A; Moyal D; Seité S
Photodermatol Photoimmunol Photomed; 2008 Aug; 24(4):164-74. PubMed ID: 18717957
[TBL] [Abstract][Full Text] [Related]
17. Determination of UVA protection factors using the persistent pigment darkening (PPD) as the end point. (Part 1). Calibration of the method.
Moyal D; Chardon A; Kollias N
Photodermatol Photoimmunol Photomed; 2000 Dec; 16(6):245-9. PubMed ID: 11132126
[TBL] [Abstract][Full Text] [Related]
18. The effect of high dose long-wave ultraviolet radiation (UVA) on epidermal melanocytes in human skin: a transmission electron microscopic study.
Beitner H
Photodermatol; 1986 Jun; 3(3):133-9. PubMed ID: 3748853
[TBL] [Abstract][Full Text] [Related]
19. The influence of pre-irradiation on the predictability of in vivo UVA protection with a new in vitro method.
Wendel V; Klette E; Wittern KP; Gers-Barlag H
Photodermatol Photoimmunol Photomed; 2003 Apr; 19(2):93-7. PubMed ID: 12945809
[TBL] [Abstract][Full Text] [Related]
20. Determination of UVA protection factors by means of immediate pigment darkening in normal skin.
Kaidbey KH; Barnes A
J Am Acad Dermatol; 1991 Aug; 25(2 Pt 1):262-6. PubMed ID: 1918464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
